← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Passage Bio PASG $11.6M	58	-8	-12%	$34M
52	52 DELISTED Adverum Biotechnologies ADVM	55	-3	-5%	$45M
53	53 DELISTED NKGen Biotech, Inc. Common Stock NKGN	55	-5	-8%	$166M
54	54 Fortress Biotech FBIO $63.7M	54	+5	+10%	$23.4M
55	55 DELISTED BRAINSTORM CELL THERAPUTC BCLI	48	+5	+12%	$20.4M
56	56 Mustang Bio MBIO $2.93M	48	-12	-20%	$3.62M
57	ATHX 57 DELISTED Athersys, Inc. Common Stock ATHX	47	-2	-4%	$2.78M
58	GMDA 58 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	44	-11	-20%	$19.6M
59	59 Mesoblast MESO $1.81B	44	+2	+5%	$7.97M
60	60 Taysha Gene Therapies TSHA $1.22B	44	-8	-15%	$13.3M
61	61 Opus Genetics IRD $337M	41	+7	+21%	$13M
62	62 Lunai Bioworks LNAI $3.74M	40	+4	+11%	$3.02M
63	GRML 63 Greenland Mines Ltd GRML $92.9M	39	+4	+11%	$93M
64	64 Neurogene NGNE $479M	39	-5	-11%	$10.5M
65	65 Solid Biosciences SLDB $615M	39	+5	+15%	$74.8M
66	DBTX 66 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	38	-1	-3%	$46.7M
67	67 DELISTED Carisma Therapeutics CARM	37	-33	-47%	$17.3M
68	68 INmune Bio INMB $45.8M	35	+1	+3%	$11.7M
69	ORTX 69 DELISTED Orchard Therapeutics plc American Depositary Shares ORTX	35	-13	-27%	$31.2M
70	70 ProKidney PROK $305M	35	+8	+30%	$391M
71	71 Abeona Therapeutics ABEO $266M	33	-7	-18%	$21.2M
72	72 Cellectis CLLS $111M	33	-6	-15%	$29.3M
73	GRCL 73 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	33	0	0%	$56.3M
74	SGTX 74 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	32	0	0%	$16.5M
75	SQZ 75 DELISTED SQZ Biotechnologies Company SQZ	32	-3	-9%	$6.36M